TCL Archive Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program November 29, 2002
TCL Archive Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data May 22, 1998
TCL Archive AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm May 8, 2013
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
TCL Archive FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review. March 23, 2001
